Curative Biosciences Inc CBDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.01 / $0.10
- Market Cap
- $47,362.04
- Volume/Avg
- 10,000 / 6,501
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 6
- Website
- http://www.CurativeBio.com
Valuation
|
Metric
|
CBDX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CBDX
Financial Strength
|
Metric
|
CBDX
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | — |
Quick Ratio
CBDX
Profitability
|
Metric
|
CBDX
|
|---|---|
Return on Assets (Normalized) | −12,044.82% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
CBDX
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Yfwmwvfbw | Yswvd | $71.2 Bil | |
ZTS
| Zoetis Inc Class A | Tppryvmv | Kzbv | $68.3 Bil | |
HLN
| Haleon PLC ADR | Ykhvyqp | Zxv | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Jfkqlybd | Fdm | $14.5 Bil | |
VTRS
| Viatris Inc | Mhdylgq | Wdlj | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zdkpzpbxf | Zsyn | $11.9 Bil | |
CTLT
| Catalent Inc | Zgqhrgx | Gwnjj | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Xmvcdbd | Pgm | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Gzxfsqhh | Tjgx | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pgrpbxltl | Mvqpcd | $3.5 Bil |